Ocena stężenia produków zaawansowanej glikacji białek i przeciwciał anty-CEL i anty-CML w surowicy pacjentów chorujących na orbitopatię Gravesa przed i po leczeniu metyloprednizolonem
Author(s) -
Janusz Strzelczyk,
Magdalena Szumska,
Aleksandra Damasiewicz-Bodzek,
Anna Krywult,
Michał Długaszek,
Justyna Czubilińska-Łada,
Kaja Gawlik,
Konrad Synowiec,
Krystyna Tyrpień-Golder,
Karolina Poczkaj,
Beata KosKudła
Publication year - 2015
Publication title -
endokrynologia polska
Language(s) - Polish
Resource type - Journals
SCImago Journal Rank - 0.413
H-Index - 27
eISSN - 2299-8306
pISSN - 0423-104X
DOI - 10.5603/ep.a2016.0047
Subject(s) - glycation , chemistry , lysine , antibody , medicine , endocrinology , biochemistry , immunology , receptor , amino acid
The glycation process is a non-enzymatic modification of proteins occurring due to the reactions of reductive carbohydrates. The glycated residues lose their biological functions, and their removal process is ineffective. They accumulate, and as a result they cause an immunological response. The aim of this study was a determination of the concentrations of advanced glycation end-products and antibodies against carboxymethyl lysine (anti-CML) and carboxyethyl lysine (anti-CEL) in the sera of Graves' orbitopathy patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom